H.B. Fuller Reports Strong Q2, Finalizes £715M Acquisition with $3B Bridge Loan, and Continues Share Buybacks
FUL sits 25% above its 52-week low of $48.71.
Summary
H.B. Fuller reported strong second-quarter financial results with significant increases in revenue, net income, and EPS, alongside a substantial improvement in free cash flow. The company also finalized a major acquisition of Advanced Medical Solutions for approximately £715 million, backed by $3.0 billion in bridge financing, and continued its share repurchase program.
Key Events · Earnings and Guidance · FUL
-
Strong Q2 Financial Performance
Net revenue increased 5.8% to $950.3 million, net income attributable to H.B. Fuller rose 62.1% to $67.8 million, and diluted EPS grew 61.8% to $1.23 for the second quarter of 2026 compared to the prior year.
-
Significant Free Cash Flow Improvement
Year-to-date free cash flow improved substantially to $12.8 million as of May 30, 2026, compared to a negative $6.7 million in the same period of 2025.
-
Major Acquisition Finalized with Bridge Financing
The company finalized the acquisition of Advanced Medical Solutions Group plc for approximately £715 million (enterprise value). This was financed by entering into up to $3.0 billion in secured and unsecured bridge credit agreements on June 25, 2026.
-
Substantial Share Repurchase Program Activity
H.B. Fuller repurchased $45.579 million of common stock during the second quarter of 2026 under its existing $300 million authorization.
Analysis · FUL · Industrial Applications And Services
This 10-Q confirms H.B. Fuller's strong financial momentum, with robust growth across key metrics and a positive shift in free cash flow. The detailed disclosure of the Advanced Medical Solutions acquisition, including the $3.0 billion bridge financing, is a critical update, signaling a significant strategic expansion. While the earnings and acquisition were previously announced, this filing provides the full financial context and details, including a material legal settlement accrual and ongoing share repurchases, which collectively present a comprehensive picture of the company's financial health and strategic direction.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 41.8% of the 328 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, FUL was trading at $60.74 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $3.3B. The 52-week trading range was $48.71 to $68.63. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.